On May 15, 2025, Mangoceuticals, Inc. entered into agreements to raise $116,249 from investors by issuing 70,454 shares of stock along with warrants, and simultaneously agreed to provide services to Levo Healthcare Consulting in exchange for 120,000 restricted shares. This move is part of their growth strategy and amends a previous $500,000 promissory note with warrants attached.